HIV type 1 (HIV-1) uses multiple mechanisms to evade the immune system, and these have stymied the development of an effective vaccine 1,2,3. One mechanism—conformational masking 4 —hides the ...
Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...